Welcome to our dedicated page for 3D Systems news (Ticker: DDD), a resource for investors and traders seeking the latest updates and insights on 3D Systems stock.
3D Systems Corporation develops additive manufacturing and digital manufacturing solutions built around 3D printers, materials, software and application engineering services. Its news commonly covers production systems for polymers and metals, NextDent dental printing and materials, SLA technology, factory software such as AddiTrak, and customer deployments in medical, dental, aerospace, defense, transportation, motorsports and industrial markets.
Company updates also include financial results, cost and efficiency programs, leadership changes, regulatory certifications for dental products, and commercial adoption of healthcare and industrial applications. These developments reflect the company’s focus on full-service solutions that combine hardware, materials, software and manufacturing expertise.
3D Systems (NYSE: DDD) has entered a Cooperative Research and Development Agreement (CRADA) with Savannah River National Laboratory (SRNL) to accelerate additive manufacturing (AM) innovation for advanced energy generation and national security applications. The partnership is anchored at SRNL’s Advanced Manufacturing Collaborative (AMC), a national laboratory-operated facility on a public university campus in South Carolina.
According to 3D Systems, the CRADA targets joint work in advanced materials, AI/ML-enabled process optimization, equipment enhancements, manufacturing systems, cybersecurity, and workforce development. Installed 3D Systems equipment at AMC will support both cutting-edge research and demonstration of production-ready AM processes. The collaboration aims to create next-generation AM materials and scalable production solutions for high-value markets including nuclear energy, aerospace and defense, and environmental technologies, while expanding advanced manufacturing training for scientists, engineers, and technicians.
3D Systems (NYSE: DDD) announced it has been awarded an additional $9 million from the U.S. Air Force under the Air Force-funded ‘Large-Format Metal 3D Printer Advanced Technology Demonstrator’ program (GEN-II DMP-1000). This phase extends the program by two years and continues work the company has been executing since 2023 on large-scale, high-temperature, flight-relevant metal 3D printing technologies.
According to 3D Systems, the new award brings total project funding to $27.4 million. Work for this phase will continue at the company’s facilities in San Diego, California, and Rock Hill, South Carolina, supporting broader efforts to develop large-format direct metal printing systems for flight-critical components at scale.
3D Systems (NYSE: DDD) announced a CEO transition plan under which Dr. Jeffrey Graves will step down as President and Chief Executive Officer and retire from the Board of Directors. He will continue as President and CEO until a successor is appointed, which the company expects later in 2026, and then serve as a consultant for six months to support the handover.
The Board has launched a comprehensive search for the next President and CEO and engaged an external executive search firm. According to 3D Systems, since joining in May 2020 Dr. Graves has driven a transformation focused on Healthcare and Industrial businesses, cost reduction initiatives, and strategic emphasis on high value growth markets such as Aerospace & Defense, Data Center Infrastructure, Med Tech, and Dental. The announcement coincides with the release of second quarter 2026 financial results and an earnings call scheduled for 8:30 a.m. Eastern Time.
3D Systems (NYSE:DDD) reported Q2 2026 revenue of $94.6 million, down 0.3% year-over-year, but up 1.4% excluding 2025 software divestitures, driven by double-digit growth in metal and polymer printer hardware. Healthcare revenue rose 6.8% to $48.1 million, while Industrial declined 6.7% to $46.5 million (3.7% decline excluding divestitures), despite over 20% growth in Aerospace & Defense and Data Center Infrastructure.
Gross margin fell to 36.4% from 38.1%. Net result shifted to a $(12.9) million loss versus prior-year income, largely due to 2025 divestiture and debt extinguishment gains. Adjusted EBITDA improved to $(0.8) million from $(4.7) million; first-half Adjusted EBITDA was positive at $1.3 million. The company issued 18.9 million shares for $53.2 million, ending Q2 with $129.0 million in cash and $96.0 million of debt. Q3 2026 guidance calls for revenue of $96–$99 million and Adjusted EBITDA of $(3) million to $(1) million.
3D Systems (NYSE:DDD)/b) reported that its Saudi Arabian joint venture, the National Additive Manufacturing and Innovation Company (NAMI), has received a from Saudi Arabia’s General Authority for Military Industries (GAMI). This authorization allows NAMI to conduct regulated military manufacturing activities in the Kingdom, placing it among a limited number of licensed Saudi companies.
According to 3D Systems, the license enhances NAMI’s role in supporting Saudi Arabia’s Vision 2030 goal of localizing over 50% of military spending by 2030 and facilitates collaboration with international defense OEMs on qualification and production of critical aerospace and defense components. NAMI targets military aerospace and defense, oil and gas, and energy generation and transmission, and operates in a Saudi additive manufacturing market estimated at over $300 million today and projected to approach $2 billion by 2034, supported by national localization priorities.
3D Systems (NYSE: DDD) announced it enabled the Defense Health Agency and Walter Reed National Military Medical Center’s 3D Medical Applications Center (3D MAC) to obtain FDA premarket clearance for the 3D MAC Titanium Cranial Plate (TCP) System, the first FDA-cleared implant granted to a point-of-care institution.
The patient-specific titanium cranial plate will be used to treat U.S. active duty personnel and warfighters with traumatic head injuries. 3D Systems supported 3D MAC with quality management systems, design optimization, additive manufacturing workflows, and regulatory strategy, reinforcing its role in point-of-care, patient-specific medical device manufacturing. The clearance is listed under FDA submission number K253116.
3D Systems (NYSE: DDD) announced that Elmet Technologies, a subsidiary of The Elmet Group (Nasdaq: ELMT), is deploying a DMP Flex 350 Triple metal additive manufacturing machine to rapidly produce advanced aerospace heat exchangers for hypersonic vehicles using C103, a high-temperature niobium-based alloy.
Elmet worked for eight years with 3D Systems’ Application Innovation Group to develop C103 process parameters and expects fast qualification of the machine, material, and process in 2026, followed by anticipated NASA 6030 certification. The system’s 350 x 350 x 350 mm build volume, three lasers, and ultra-low oxygen environment are intended to support high-quality, repeatable, domestic production and strengthen the US defense supply chain.
3D Systems (NYSE: DDD) will release its second quarter 2026 financial results after the U.S. market close on Monday, August 3, 2026. The company will discuss the results via conference call and simultaneous webcast on Tuesday, August 4, 2026 at 8:30 a.m. Eastern Time, with a replay available online.
3D Systems (NYSE: DDD) priced a previously announced upsized underwritten public offering of 16,393,443 shares of common stock at $3.05 per share, for expected gross proceeds of about $50 million. The deal, managed by Needham & Company and Craig-Hallum, is expected to close on June 5, 2026, subject to customary conditions.
The company granted underwriters a 30-day option to buy up to an additional 2,459,016 shares at the same public price, less underwriting discounts and commissions. The SEC declared the related registration statement effective on May 27, 2026.
3D Systems (NYSE: DDD) announced a proposed underwritten public offering of $40 million of its common stock, all sold by the company. The firm plans to grant underwriters a 15% overallotment option. Needham & Company and Craig-Hallum are joint book-running managers.
A related SEC registration statement was declared effective on May 27, 2026. Final pricing, number of shares, and other terms will be detailed in a final prospectus supplement, and the offering remains subject to market conditions.